Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. 2004

P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France. morice@igr.fr

BACKGROUND The aim of this study was to determine the value of routine follow-up for the detection of recurrence in patients treated for cervical cancer. METHODS From 1986 to 1998, 583 women with stage I and II cervical carcinoma were treated with combined surgery-radiation therapy. After treatment, follow-up was based on clinical examination, a systematic Pap smear and radiography (chest X-ray and abdomino-pelvic ultrasonography). RESULTS Forty-five patients had recurrence observed with a delay > or = 6 months following the end of treatment. Thirty-eight patients had symptoms and seven were asymptomatic at the time of their recurrence. Among asymptomatic patients only two recurrences were diagnosed following routine examinations. Survival is similar in asymptomatic and symptomatic recurrent patients. CONCLUSIONS In conclusion, follow-up of patients treated for cervical cancer based on routine Pap smears and systematic radiography does not permit earlier detection of recurrence and does not increase survival.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010808 Physical Examination Systematic and thorough inspection of the patient for physical signs of disease or abnormality. Physical Exam,Examination, Physical,Physical Examinations and Diagnoses,Exam, Physical,Examinations, Physical,Exams, Physical,Physical Examinations,Physical Exams
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
May 2001, European journal of cancer (Oxford, England : 1990),
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
April 2002, Breast (Edinburgh, Scotland),
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
January 1993, European journal of cancer (Oxford, England : 1990),
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
October 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
February 1994, Gynecologic oncology,
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
July 2016, Obstetrics & gynecology science,
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
October 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
July 1996, International journal of radiation oncology, biology, physics,
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
July 2012, Archives of gynecology and obstetrics,
P Morice, and C Deyrolle, and A Rey, and D Atallah, and P Pautier, and S Camatte, and A Thoury, and C Lhomme, and C Haie-Meder, and D Castaigne
March 2016, BMC cancer,
Copied contents to your clipboard!